Avalo Therapeutics: Funding, Investors & Team (Sep 2026)
Avalo Therapeutics is a clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in areas of significant unmet clinical need.
Avalo Therapeutics has raised $431M across 1 funding round on record, the most recent an undisclosed round of $431M announced in May 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Avalo Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2026.
Avalo Therapeutics Funding Rounds
Avalo Therapeutics Founders and Leadership Team
Contact details for the Avalo Therapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Avalo Therapeutics Funding Compared to Other Biotechnology Startups
Avalo Therapeutics' latest round of $431M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Avalo Therapeutics in Biotechnology and Rockville
Companies Similar to Avalo Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Avalo Therapeutics Funding FAQs
What does Avalo Therapeutics do?
Avalo Therapeutics is a clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in areas of significant unmet clinical need.
How much funding has Avalo Therapeutics raised?
Avalo Therapeutics has raised $431M across 1 round on record. The most recent is an undisclosed round of $431M announced in May 2026.
When did Avalo Therapeutics last raise funding?
Avalo Therapeutics' most recent funding round on record is an undisclosed round of $431M, announced in May 2026.
Who founded Avalo Therapeutics?
FundedIQ lists Garry Neil (Founder) at Avalo Therapeutics.
Where is Avalo Therapeutics headquartered?
Avalo Therapeutics is based in Rockville, Maryland, United States.
How many employees does Avalo Therapeutics have?
Avalo Therapeutics is in the 11-50 employee band.
How does Avalo Therapeutics' funding compare to other Biotechnology startups?
Avalo Therapeutics' latest round of $431M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Avalo Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Avalo Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.